Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Autologous Costal Chondrocyte
Therapeutic Area : Musculoskeletal
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase 3 Clinical Trial of CartiLife® in Korea
Details : Undisclosed
Product Name : CartiLife
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
September 21, 2021
Lead Product(s) : Autologous Costal Chondrocyte
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Autologous Costal Chondrocyte
Therapeutic Area : Musculoskeletal
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase 2 Clinical Trial of CartiLife® in the United States
Details : Undisclosed
Product Name : CartiLife
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
February 09, 2021
Lead Product(s) : Autologous Costal Chondrocyte
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chondrocytes
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Recipient : Mundipharma
Deal Size : Undisclosed
Deal Type : Agreement
Mundipharma, Biosolution to market CartiLife in South Korea
Details : Under the agreement, Mundipharma obtains the rights to market and distribute CartiLife® in South Korea.
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
June 01, 2020
Lead Product(s) : Chondrocytes
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Recipient : Mundipharma
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Autologous Chondrocyte
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase II
Sponsor : Kyunghee University Medical Center | Gangnam Severance Hospital | Severance Hospital | GCP unit, Copenhagen University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Assess the Efficacy and Safety of Treatment of Articular Cartilage Lesions With CartiLife®
Details : Undisclosed
Product Name : CartiLife
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
June 04, 2018
Lead Product(s) : Autologous Chondrocyte
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase II
Sponsor : Kyunghee University Medical Center | Gangnam Severance Hospital | Severance Hospital | GCP unit, Copenhagen University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Autologous Chondrocyte
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase I
Sponsor : Kyung Hee University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Assess the Safety of Treatment of Articular Cartilage Lesions With CartiLife®
Details : Undisclosed
Product Name : CartiLife
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
May 07, 2018
Lead Product(s) : Autologous Chondrocyte
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase I
Sponsor : Kyung Hee University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable